NCT01153594

Brief Summary

The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
446

participants targeted

Target at P50-P75 for phase_3

Timeline
Completed

Started Feb 2004

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2004

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2008

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2009

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

June 29, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

June 30, 2010

Completed
Last Updated

June 30, 2010

Status Verified

June 1, 2010

Enrollment Period

4.3 years

First QC Date

June 29, 2010

Last Update Submit

June 29, 2010

Conditions

Keywords

Substance Use DisordersRelapseRecoveryDisease ManagementLong term outcomesAddiction Treatment

Outcome Measures

Primary Outcomes (1)

  • Time to First Alcohol or Drug Treatment Re-Entry

    Days to readmission was calculated as the number of days from the date of the quarterly follow-up interview where the client first reported being in need of treatment (see below) to the date of the first subsequent intake to alcohol or other drug treatment following that interview.

    Quarterly from random assignment until month 48

Secondary Outcomes (8)

  • Any Treatment Re-Entry

    Quarterly from random assignment until month 48

  • Times Re-entered Treatment Time Frame

    Quarterly from random assignment until month 48 Description:

  • Total Days of Treatment

    Quarterly from random assignment until month 48

  • Quarters with 7 days Outpatient or 14 days Residential

    Quarterly from random assignment until month 48

  • Quarters Needing Treatment

    Quarterly from random assignment until month 48

  • +3 more secondary outcomes

Study Arms (2)

Recovery Management Checkups (RMC)

EXPERIMENTAL

Participants in the RMC group are interviewed quarterly. When they were found to be in need of treatment, the participant was transferred from the interviewer to a linkage manager to receive the intervention (described next). They were also able to re-enter treatment on their own and naturally cycle through multiple periods of substance use, treatment, incarceration and recovery.

Behavioral: Recovery Management Checkups (RMC)

Control Group

NO INTERVENTION

Participants in the control group are interviewed quarterly. While they do not receive any active intervention from the research team, they are able to re-enter treatment on their own and naturally cycle through multiple periods of substance use, treatment, incarceration and recovery.

Interventions

After interviewers completed the quarterly research interview and determined participants' eligibility and need for early re-intervention, they transferred RMC participants who were eligible and in need to a Linkage Manager. Using motivational interviewing, the Linkage Manager: a) provided feedback to participants regarding their current substance use and related problems, b) discussed implications of managing addiction as a chronic condition, c) discussed treatment barriers and solutions, d) assessed and discussed level of motivation for treatment, e) scheduled treatment appointments, f) accompanied participants to treatment intake and stayed through the process, and g) implemented Engagement and Retention Protocol during the 14 days of treatment

Recovery Management Checkups (RMC)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • any substance use in the past 90 days
  • any past-year symptoms of substance use disorders.

You may not qualify if:

  • under 18
  • lived or planned to move outside Chicago within 12 months
  • sentenced to a confined environment most of the next 12 months
  • mandated to treatment because of a driving under the influence offense
  • were not fluent in English or Spanish
  • were cognitively unable to provide informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chestnut Health Systems

Chicago, Illinois, 60610, United States

Location

Related Publications (5)

  • Scott CK, Sonis J, Creamer M, Dennis ML. Maximizing follow-up in longitudinal studies of traumatized populations. J Trauma Stress. 2006 Dec;19(6):757-69. doi: 10.1002/jts.20186.

    PMID: 17195975BACKGROUND
  • Dennis M, Scott CK. Managing addiction as a chronic condition. Addict Sci Clin Pract. 2007 Dec;4(1):45-55. doi: 10.1151/ascp074145.

    PMID: 18292710BACKGROUND
  • Rush BR, Dennis ML, Scott CK, Castel S, Funk RR. The interaction of co-occurring mental disorders and recovery management checkups on substance abuse treatment participation and recovery. Eval Rev. 2008 Feb;32(1):7-38. doi: 10.1177/0193841X07307532.

  • Scott CK, Dennis ML. Results from two randomized clinical trials evaluating the impact of quarterly recovery management checkups with adult chronic substance users. Addiction. 2009 Jun;104(6):959-71. doi: 10.1111/j.1360-0443.2009.02525.x. Epub 2009 Mar 13.

  • McCollister KE, French MT, Freitas DM, Dennis ML, Scott CK, Funk RR. Cost-effectiveness analysis of Recovery Management Checkups (RMC) for adults with chronic substance use disorders: evidence from a 4-year randomized trial. Addiction. 2013 Dec;108(12):2166-74. doi: 10.1111/add.12335. Epub 2013 Oct 9.

MeSH Terms

Conditions

Substance-Related DisordersRecurrence

Condition Hierarchy (Ancestors)

Chemically-Induced DisordersMental DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Michael L Dennis, Ph.D.

    Chestnut Health Systems

    PRINCIPAL INVESTIGATOR
  • Christy K Scott, Ph.D.

    Chestnut Health Systems

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

June 29, 2010

First Posted

June 30, 2010

Study Start

February 1, 2004

Primary Completion

June 1, 2008

Study Completion

June 1, 2009

Last Updated

June 30, 2010

Record last verified: 2010-06

Locations